Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomallei
Abstract
The in vitro activity and in vivo efficacy of delafloxacin were evaluated against the causative pathogen of melioidosis, Burkholderia pseudomallei . Delafloxacin MICs were determined by broth microdilution according to CLSI guidelines for 30 isolates of B. pseudomallei .
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 17, 2021
- Source ID
- 10.1128/aac.00736-21
Entities
People
- Erin Duffy
- Mark Hickman
- Sandra P. McCurdy
- Stephanie Halasohoris
- Steven D. Zumbrun
Organizations
- Melinta Therapeutics
- United States Army Medical Research Institute of Infectious Diseases
- United States Department of Defense